MedPath

UNIVERSITY OF KENTUCKY

UNIVERSITY OF KENTUCKY logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Private
Established
1865-01-01
Employees
10K
Market Cap
-
Website
http://www.uky.edu

A Phase I Study of AR-67 (7-t-butyldimethylsilyl-10-hydroxycamptothecin) Given on Days 1, 4 8, 12 & 15 of an Every 21-day Cycle in Adult Patients With Refractory or Metastatic Solid Malignancies

Phase 1
Completed
Conditions
Solid Malignancies
Interventions
Drug: 7-t-butyldimethylsilyl-10-hydroxycamptothecin
First Posted Date
2010-09-15
Last Posted Date
2013-08-14
Lead Sponsor
University of Kentucky
Target Recruit Count
3
Registration Number
NCT01202370
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States

Intrauterine Device (IUD) Placement at the Time of Cesarean Section

Withdrawn
Conditions
Intrauterine Device Placement
First Posted Date
2009-09-29
Last Posted Date
2016-12-22
Lead Sponsor
University of Kentucky
Registration Number
NCT00986089

Effects of Selective Laser Trabeculoplasty

Terminated
Conditions
Glaucoma
First Posted Date
2009-09-29
Last Posted Date
2013-04-24
Lead Sponsor
University of Kentucky
Target Recruit Count
30
Registration Number
NCT00986141
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Kentucky, Lexington, Kentucky, United States

Trichloroethylene (TCE) Exposure in an Industrial Population

Completed
Conditions
Parkinson's Disease
First Posted Date
2009-02-09
Last Posted Date
2012-06-07
Lead Sponsor
University of Kentucky
Target Recruit Count
27
Registration Number
NCT00839514
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Kentucky, Lexington, Kentucky, United States

Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)

Phase 2
Withdrawn
Conditions
Chronic Lymphocytic Leukemia
Interventions
First Posted Date
2008-09-25
Last Posted Date
2012-01-11
Lead Sponsor
University of Kentucky
Registration Number
NCT00758693
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Kentucky, Lexington, Kentucky, United States

An Evaluation Of Respiratory Samples for Staphylococcus Resistance PatternsS

Completed
Conditions
Methicillin-resistant Staphylococcal Aureus Pneumonia
First Posted Date
2008-09-17
Last Posted Date
2011-03-23
Lead Sponsor
University of Kentucky
Target Recruit Count
1250
Registration Number
NCT00754273
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Kentucky Medical Center, Lexington, Kentucky, United States

Agonist Replacement Therapy for Cocaine Dependence

Phase 1
Completed
Conditions
Cocaine Dependence
Interventions
First Posted Date
2008-06-13
Last Posted Date
2012-03-01
Lead Sponsor
University of Kentucky
Target Recruit Count
46
Registration Number
NCT00697138
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Kentucky Medical Center, Lexington, Kentucky, United States

Kinematics of Youth (Age 12-15) on Stationary All Terrain Vehicles

Completed
Conditions
Healthy
First Posted Date
2008-06-06
Last Posted Date
2011-02-21
Lead Sponsor
University of Kentucky
Target Recruit Count
40
Registration Number
NCT00692029
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Kentucky, Lexington, Kentucky, United States

Oral Contraceptives and Asthma Control

Withdrawn
Conditions
Asthma
Regulatory T Cell Function
First Posted Date
2008-04-21
Last Posted Date
2013-08-09
Lead Sponsor
University of Kentucky
Registration Number
NCT00662051
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Kentucky, Lexington, Kentucky, United States

Oral Infections: Dietary Regulation of Local and Systemic Inflammatory Responses

Not Applicable
Completed
Conditions
Periodontal Attachment Loss
First Posted Date
2008-03-11
Last Posted Date
2011-04-12
Lead Sponsor
University of Kentucky
Target Recruit Count
126
Registration Number
NCT00632957
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Kentucky College of Dentistry, Lexington, Kentucky, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath